imipramine has been researched along with Basal Ganglia Diseases in 6 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amoxapine was associated with significant neuroleptic activity in plasma." | 2.65 | Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. ( Cohen, BM; Curren, FC; Falk, WE; Gelenberg, AJ; Hicks, RH; Lydiard, RB; McCormick, MG; Wojcik, JD, 1984) |
| "The rabbit syndrome is an extrapyramidal side effect associated with chronic neuroleptic therapy." | 1.28 | Rabbit syndrome, antidepressant use, and cerebral perfusion SPECT scan findings. ( Fornazzari, L; Ichise, M; Remington, G; Smith, I, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| POROT, M | 1 |
| PASCALIS, G | 1 |
| Tahiroglu, AY | 1 |
| Avci, A | 1 |
| Gelenberg, AJ | 1 |
| Wojcik, JD | 1 |
| Lydiard, RB | 1 |
| McCormick, MG | 1 |
| Falk, WE | 1 |
| Hicks, RH | 1 |
| Curren, FC | 1 |
| Cohen, BM | 1 |
| Fornazzari, L | 1 |
| Ichise, M | 1 |
| Remington, G | 1 |
| Smith, I | 1 |
| Dencker, SJ | 1 |
| Frankenberg, K | 1 |
| Malm, U | 1 |
| Zell, B | 1 |
| Diebold, K | 1 |
2 trials available for imipramine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients.
Topics: Adolescent; Adult; Ambulatory Care; Amoxapine; Basal Ganglia Diseases; Clinical Trials as Topic; Dep | 1984 |
A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as | 1973 |
4 other studies available for imipramine and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Neurological complications during imipramine therapy].
Topics: Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Imipramine; Nervous System Diseases; Parkins | 1959 |
Imipramine, methylphenidate and valproic acid-related EPS in a child: a case report.
Topics: Basal Ganglia Diseases; Child; Female; Humans; Imipramine; Methylphenidate; Valproic Acid | 2007 |
Rabbit syndrome, antidepressant use, and cerebral perfusion SPECT scan findings.
Topics: Basal Ganglia Diseases; Cerebrovascular Circulation; Depressive Disorder; Female; Humans; Imipramine | 1991 |
[Polythymolepsy (combined use of thymoleptics) in cases of endogenous depression].
Topics: Amitriptyline; Antidepressive Agents; Basal Ganglia Diseases; Depression; Dibenzazepines; Drug Thera | 1971 |